您当前的位置:
首页 >
文章列表页 >
Targeting the epigenome to reinvigorate T cells for cancer immunotherapy
REVIEW | 更新时间:2025-12-13
    • Targeting the epigenome to reinvigorate T cells for cancer immunotherapy

    • Targeting the epigenome to reinvigorate T cells for cancer immunotherapy

    • “在癌症免疫治疗领域,研究人员总结了导致肿瘤微环境中T细胞耗竭的表观遗传学机制,并讨论了靶向表观遗传学调节因子用于免疫治疗的治疗潜力。这为构建涉及免疫刺激剂和表观遗传疗法的治疗范式奠定了基础。”
    • Dian Xiong ,Lu Zhang ,Zhi-Jun Sun
    • MMR 2024年11卷第6期 页码:863-886
    • DOI: 10.1186/s40779-023-00496-2     

      中图分类号:

    移动端阅览

  •  
  •  
  • AI导读

  • HTML全文

  • 图( 4 ) 表( 1 )

  • 参考文献

  • 出版信息

  • 数据统计

28

浏览量

38

下载量

0

CSCD

文章被引用时,请邮件提醒。
提交
工具集
  • BibTeX下载
  • Endnote下载
  • RefMan 下载
  • NoteExpress下载
  • NoteFirst下载

相关文章

Immune microenvironment dynamics in pregnant patients with concomitant autoimmune diseases: mechanisms, challenges, and clinical significance
Maladaptive reorganization of mediodorsal thalamus as a central mechanism in neuropathic pain-related sleep disorders
Octopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain

相关作者

暂无数据

相关机构

暂无数据